Cetics
News

 News


CoronaVac Symposium: watch all the speeches of the events that gathered researchers from five countries
10/12/21

Through the eyes of a specialist: immunogenicity, safety of the third dose and vaccination on specific populations during the third day of the CoronaVac Symposium
10/12/21

The ignorance of not using CoronaVac to vaccinate children is unforgivable, affirms the founder and ex-president of Anvisa
09/12/21

It was the worst professional experience of my life, said Thelma de Assis about working in the front line against Covid in Manaus
09/12/21

Vaccine passport is a fundamental measure and is already used for the Yellow Fever; it is not something new, says the sanitary doctor
09/12/21

The negationism removes from the population the opportunity to live a better life, says professor from USP
09/12/21

Doctors and communicators debate victories and challenges of the vaccination during the last discussion table of the CoronaVac Symposium
09/12/21

Closure of the international symposium reinforces the need of vaccinating children and immunosuppressed individuals with CoronaVac
09/12/21

Europe needs vaccines of inactivated virus to fight against the Covid-19, reinforces the researcher of the University from Barcelona
09/12/21

Children are even more susceptible to coronavirus and must be protected, reinforce the specialists
09/12/21

Chinese study testifies that CoronaVac is efficient for people with diverse comorbidities
09/12/21

The Brazilian people did not succumb to the negationism and got in line to receive the vaccine, says epidemiologist from USP
09/12/21

Preliminary results of the clinical trials on phase 3 in Chile demonstrates that CoronaVac is efficient for children and teenagers between three and 17 years of age
09/12/21

Third dose of CoronaVac is efficient to recover immune response in immunosuppressed individuals, indicates research from HC and USP
09/12/21

CoronaVac has a good safety profile for population above 3 years old and for the third dose of homologous vaccination, says specialist in pharmacovigilance
09/12/21

Third dose of CoronaVac maintains the level of antibodies high for at least a year, reveals Chinese research
09/12/21

We must vaccinate children to contain the transmission and the emergence of new variants, affirms the infectologist
08/12/21

Through the eyes of a specialist: Isolation of SARS-CoV-2, immunogenicity, booster dose and vaccination on individuals that already had Covid, on the second day of the CoronaVac Symposium
08/12/21

Duration of immunity and third dose of vaccines from inactivated viruses in the discussions of the second day of the CoronaVac Symposium
08/12/21

Evidences indicates that inactivated virus vaccines works against omicron
08/12/21

Vaccination against Covid-19 can be annual as long the vaccines are updated, says the scientists during International Symposium
08/12/21

“CoronaVac produces neutralizing antibodies for variants on high levels”, said researcher from USP
08/12/21

All evidence indicates the safety of the vaccines of inactivated viruses such as CoronaVac on children, affirms scientist of the Chinese CDC
08/12/21

China has already immunized over 90% of the olders than 12 years of age; vaccines of inactive virus as CoronaVac predominates
08/12/21

CoronaVac simulates the real infection and is more efficient against reinfection, points out the virologist
08/12/21

“We may have a wonderful and efficient vaccine, but if the people do not think that they need to get vaccinated this is all useless”, emphasizes chilean researcher
08/12/21

The ones vaccinated with CoronaVac that were infected with Covid-19 previously presented more antibodies than the non infected, says a Turkish study
08/12/21

Third dose of CoronaVac regains the protection of neutralizing antibodies in 20 times, affirms chinese researcher
08/12/21

Through the eyes of a specialist: A summary of the main studies presented during the first day of the CoronaVac Symposium
07/12/21

Doctors defend agility at vaccinating children against Covid-19 during discussion table at CoronaVac Symposium
07/12/21

Why is it wrong to compare the efficacy of the vaccines? Dimas Covas and researcher from Project S, responds
07/12/21

Confidence in the fight against the new variants assinalates discussions of the first day of the CoronaVac Symposium
07/12/21

Studies suggest that interchangeability of vaccines may be more effective to immunize against Covid-19
07/12/21

Effectiveness of CoronaVac is higher on eldery than in other age group, apoints Serrana data
07/12/21

Studies with Project S may foretell pandemic events in the real world
07/12/21

Sinovac is already working on an actualization of CoronaVac to oppose the Omicron
07/12/21

“CoronaVac is highly safe and tolerable for children” says the infectologist of Hospital das Clinicas of USP
07/12/21

CoronaVac on the third dose was “highly accepted, more than expected” , affirms the assessor of the Health Ministry from Chile
07/12/21

International symposium begins with statements by Butantan and Sinovac and expectation of updating CoronaVac against variants
07/12/21

Turkish Researcher explains the study with CoronaVac that showed 83,5% of the efficacy in healthy people and with comorbidities
07/12/21

International symposium begins with statements by Butantan and Sinovac and expectation of updating CoronaVac against variants
07/12/21

Vice President of Sinovac presents step-by-step development of Coronavac in symposium
07/12/21

International symposium begins with statements by Butantan and Sinovac and expectation of updating CoronaVac against variants
07/12/21

It is of unanimous opinion that the third dose of CoronaVac is safe and benefitial, says pediatric specialist
06/12/21

Project S developments, with serology and household survey, are a world reference in the fight against Covid-19
06/12/21

Coronavac directed public policy decisions and is the protagonist of clinical trials in Brazil, says master in health sciences
06/12/21

Projeto S's pioneering methodology enables safe vaccination without the use of placebo in clinical trials
06/12/21

It is wrong to compare the efficacy of vaccines that have not been tested in the same way, explains doctor of science
03/12/21

Serrana study shows 80.5% effectiveness of CoronaVac against Covid-19 cases and 94.9% against deaths; vaccination protected even the non-vaccinated against the gamma variant
03/12/21

See the countries that have authorized CoronaVac for children aged 3 and over
03/12/21

CoronaVac's success is due to Butantan's extensive experience, says specialist in health surveillance
03/12/21

Spanish researcher mediating symposium evaluates CoronaVac's technology as the most effective in fighting the pandemic
03/12/21

Science should dictate the course of fighting the pandemic, says doctor in pulmonology
02/12/21

Turkish researchers to discuss high efficacy of CoronaVac in healthy people with comorbidities at symposium
02/12/21

CoronaVac production in Brazil is complex and involves highly trained teams, says production specialist
02/12/21

International CoronaVac symposium will have real-time news coverage and simultaneous interpretation
02/12/21

Brazilian and international researchers assess immunity of vaccinated elderly, adolescents and children on the third day of the CoronaVac Symposium
01/12/21

CoronaVac caused the number of deaths among the elderly in Brazil and in the world to plummet, says doctor of science
01/12/21

CoronaVac is used in 45 countries: understand the distribution of the vaccine that represents 25% of all immunizers against Covid-19
01/12/21

At event, researchers from Chile will demonstrate the impact and effectiveness of CoronaVac in the general population and among children
01/12/21

It is important to give back to society all the scientific study that supported CoronaVac, says doctor in immunology
01/12/21

Studies in China, South Africa, Chile, Malaysia and the Philippines show that CoronaVac is safe for children and adolescents
01/12/21

At symposium, chinese scientists presents CoronaVac data that testifies the benefits of the reinforcement dose and efficiency in children and eldery
30/11/21

CoronaVac Symposium discusses the potency and duration of the reinforcement dose of the vaccine that began the immunization in Brazil
30/11/21

Five studies to understand why CoronaVac is the best vaccine for those with comorbidity
29/11/21

Efficacy and safety of the vaccine are the main topics on the opening of CoronaVac Symposium
29/11/21